HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?

Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):568-9. doi: 10.1038/ncpgasthep0337.
No abstract available

Publication types

  • Comment